SHPH - Shuttle Pharmaceuticals Holdings, Inc.
0.6701
-0.025 -3.716%
Share volume: 29,551
Last Updated: Wed 05 Feb 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.20%
PREVIOUS CLOSE
CHG
CHG%
$0.70
-0.04
-0.06%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-09-04 | 2024-09-04 | 2024-11-13 | |
| Assets | ||||
| Total Assets | 4.754 M | 2.813 M | 673.568 K | |
| Current Assets | 4.411 M | 2.485 M | 361.351 K | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 81.534 K | 0.000 | 101.651 K | |
| Short Term Investments | 2.789 M | 1.643 M | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.399 M | 695.594 K | 156.656 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 22.915 K | 21.953 K | 21.160 K | |
| Other Assets | 319.987 K | 305.712 K | 291.057 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 4.754 M | 2.813 M | 673.568 K | |
| Total liabilities | 1.992 M | 2.012 M | 1.989 M | |
| Total current liabilities | 1.489 M | 1.385 M | 1.659 M | |
| Accounts Payable | 347.556 K | 364.891 K | 1.348 M | |
| Other liabilities | 503.217 K | 626.944 K | 329.712 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 503.217 K | 626.944 K | 329.712 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.761 M | 801.434 K | -1.315 M | |
| Common stock | 29.926 M | 29.997 M | 31.664 M | |
| Retained earnings | -27.164 M | -29.196 M | -32.980 M |